{"id":5009,"date":"2020-05-09T09:07:54","date_gmt":"2020-05-09T09:07:54","guid":{"rendered":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/?p=5009"},"modified":"2020-05-09T09:07:56","modified_gmt":"2020-05-09T09:07:56","slug":"covid-19-coronavirus-sars-cov-2","status":"publish","type":"post","link":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/covid-19-coronavirus-sars-cov-2\/","title":{"rendered":"COVID-19 (Coronavirus SARS-CoV-2)"},"content":{"rendered":"<p>Medikament\u00f6se Therapie bei COVID-19: Was wissen wir zu den aktuell empfohlenen, aber noch nicht zugelassenen Arzneimitteln? Ein spezifisch f\u00fcr die Behandlung von COVID-19 zugelassenes Medikament gibt es derzeit weltweit nicht, jedoch eine Vielzahl von Wirkstoffen, deren antivirale Aktivit\u00e4t gegen SARS-CoV-2 bekannt ist oder postuliert wird (1-6). \u201eRepurposed Drugs\u201c lautet das Wort der Stunde in der [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medikament\u00f6se Therapie bei COVID-19: Was wissen wir zu den aktuell empfohlenen, aber noch nicht zugelassenen Arzneimitteln? Ein spezifisch f\u00fcr die Behandlung von COVID-19 zugelassenes Medikament gibt es derzeit weltweit nicht, jedoch eine Vielzahl von Wirkstoffen, deren antivirale Aktivit\u00e4t gegen SARS-CoV-2 bekannt ist oder postuliert wird (1-6). \u201eRepurposed Drugs\u201c lautet das Wort der Stunde in der [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","footnotes":""},"categories":[1],"tags":[],"class_list":["post-5009","post","type-post","status-publish","format-standard","hentry","category-allgemein"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>COVID-19 (Coronavirus SARS-CoV-2) - Der Arzneimittelbrief<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/covid-19-coronavirus-sars-cov-2\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COVID-19 (Coronavirus SARS-CoV-2) - Der Arzneimittelbrief\" \/>\n<meta property=\"og:description\" content=\"Medikament\u00f6se Therapie bei COVID-19: Was wissen wir zu den aktuell empfohlenen, aber noch nicht zugelassenen Arzneimitteln? Ein spezifisch f\u00fcr die Behandlung von COVID-19 zugelassenes Medikament gibt es derzeit weltweit nicht, jedoch eine Vielzahl von Wirkstoffen, deren antivirale Aktivit\u00e4t gegen SARS-CoV-2 bekannt ist oder postuliert wird (1-6). \u201eRepurposed Drugs\u201c lautet das Wort der Stunde in der [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/covid-19-coronavirus-sars-cov-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Der Arzneimittelbrief\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/derarzneimittelbrief.de\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-09T09:07:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-05-09T09:07:56+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2012\/06\/logo_amb_neu.jpg\" \/>\n<meta name=\"author\" content=\"NBF\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"NBF\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/covid-19-coronavirus-sars-cov-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/covid-19-coronavirus-sars-cov-2\\\/\"},\"author\":{\"name\":\"NBF\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/0be2a0edbca5eeb8b297cd04e33dd361\"},\"headline\":\"COVID-19 (Coronavirus SARS-CoV-2)\",\"datePublished\":\"2020-05-09T09:07:54+00:00\",\"dateModified\":\"2020-05-09T09:07:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/covid-19-coronavirus-sars-cov-2\\\/\"},\"wordCount\":658,\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/covid-19-coronavirus-sars-cov-2\\\/\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/covid-19-coronavirus-sars-cov-2\\\/\",\"name\":\"COVID-19 (Coronavirus SARS-CoV-2) - Der Arzneimittelbrief\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\"},\"datePublished\":\"2020-05-09T09:07:54+00:00\",\"dateModified\":\"2020-05-09T09:07:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/0be2a0edbca5eeb8b297cd04e33dd361\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/covid-19-coronavirus-sars-cov-2\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/covid-19-coronavirus-sars-cov-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/covid-19-coronavirus-sars-cov-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"COVID-19 (Coronavirus SARS-CoV-2)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\",\"name\":\"Der Arzneimittelbrief\",\"description\":\"Unabh\u00e4ngige Arzneimittelinformationen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/0be2a0edbca5eeb8b297cd04e33dd361\",\"name\":\"NBF\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4a927f09adb02a660fe4d21c45113498c199505b1b4442412daaba18369777c1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4a927f09adb02a660fe4d21c45113498c199505b1b4442412daaba18369777c1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4a927f09adb02a660fe4d21c45113498c199505b1b4442412daaba18369777c1?s=96&d=mm&r=g\",\"caption\":\"NBF\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"COVID-19 (Coronavirus SARS-CoV-2) - Der Arzneimittelbrief","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/covid-19-coronavirus-sars-cov-2\/","og_locale":"de_DE","og_type":"article","og_title":"COVID-19 (Coronavirus SARS-CoV-2) - Der Arzneimittelbrief","og_description":"Medikament\u00f6se Therapie bei COVID-19: Was wissen wir zu den aktuell empfohlenen, aber noch nicht zugelassenen Arzneimitteln? Ein spezifisch f\u00fcr die Behandlung von COVID-19 zugelassenes Medikament gibt es derzeit weltweit nicht, jedoch eine Vielzahl von Wirkstoffen, deren antivirale Aktivit\u00e4t gegen SARS-CoV-2 bekannt ist oder postuliert wird (1-6). \u201eRepurposed Drugs\u201c lautet das Wort der Stunde in der [&hellip;]","og_url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/covid-19-coronavirus-sars-cov-2\/","og_site_name":"Der Arzneimittelbrief","article_publisher":"http:\/\/www.facebook.com\/derarzneimittelbrief.de","article_published_time":"2020-05-09T09:07:54+00:00","article_modified_time":"2020-05-09T09:07:56+00:00","og_image":[{"url":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2012\/06\/logo_amb_neu.jpg","type":"","width":"","height":""}],"author":"NBF","twitter_misc":{"Verfasst von":"NBF","Gesch\u00e4tzte Lesezeit":"3\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/covid-19-coronavirus-sars-cov-2\/#article","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/covid-19-coronavirus-sars-cov-2\/"},"author":{"name":"NBF","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/0be2a0edbca5eeb8b297cd04e33dd361"},"headline":"COVID-19 (Coronavirus SARS-CoV-2)","datePublished":"2020-05-09T09:07:54+00:00","dateModified":"2020-05-09T09:07:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/covid-19-coronavirus-sars-cov-2\/"},"wordCount":658,"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/covid-19-coronavirus-sars-cov-2\/","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/covid-19-coronavirus-sars-cov-2\/","name":"COVID-19 (Coronavirus SARS-CoV-2) - Der Arzneimittelbrief","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website"},"datePublished":"2020-05-09T09:07:54+00:00","dateModified":"2020-05-09T09:07:56+00:00","author":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/0be2a0edbca5eeb8b297cd04e33dd361"},"breadcrumb":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/covid-19-coronavirus-sars-cov-2\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/covid-19-coronavirus-sars-cov-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/covid-19-coronavirus-sars-cov-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/"},{"@type":"ListItem","position":2,"name":"COVID-19 (Coronavirus SARS-CoV-2)"}]},{"@type":"WebSite","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/","name":"Der Arzneimittelbrief","description":"Unabh\u00e4ngige Arzneimittelinformationen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/0be2a0edbca5eeb8b297cd04e33dd361","name":"NBF","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/4a927f09adb02a660fe4d21c45113498c199505b1b4442412daaba18369777c1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4a927f09adb02a660fe4d21c45113498c199505b1b4442412daaba18369777c1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4a927f09adb02a660fe4d21c45113498c199505b1b4442412daaba18369777c1?s=96&d=mm&r=g","caption":"NBF"}}]}},"_links":{"self":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/5009","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/comments?post=5009"}],"version-history":[{"count":1,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/5009\/revisions"}],"predecessor-version":[{"id":5010,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/5009\/revisions\/5010"}],"wp:attachment":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/media?parent=5009"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/categories?post=5009"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/tags?post=5009"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}